AβPP A713T mutation in late onset alzheimer's disease with cerebrovascular lesions

Journal of Alzheimer's Disease

Volumn 17, Issue 2, 2009, Pages 383-389

  Bernardi, Livia ^a   Geracitano, Silvana ^a   Colao, Rosanna ^a   Puccio, Gianfranco ^a   Gallo, Maura ^a   Anfossi, Maria ^a   Frangipane, Francesca ^a   Curcio, Sabrina A M ^a   Mirabelli, Maria ^a   Tomaino, Carmine ^a   Vasso, Franca ^a   Smirne, Nicoletta ^a   Maletta, Raffaele ^a   Bruni, Amalia C ^a  

^a Centro Regionale di Neurogenetica   (Italy)

Author keywords

Alzheimer's disease; Amyloid ; A PP A713T mutation; Cerebrovascular lesions; Vascular risk factors; White matter lesions

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MUTANT PROTEIN; APOLIPOPROTEIN E4;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR DISEASE; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC EPIDEMIOLOGY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOGENICITY; PEDIGREE; PREVALENCE; PRIORITY JOURNAL; COMPUTER ASSISTED TOMOGRAPHY; DAILY LIFE ACTIVITY; EXON; FAMILY HEALTH; GENETICS; MENTAL HEALTH; METHODOLOGY; MIDDLE AGED; MUTATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PATHOLOGY; RISK FACTOR;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEIN E4; CEREBROVASCULAR DISORDERS; DNA MUTATIONAL ANALYSIS; EXONS; FAMILY HEALTH; FEMALE; HUMANS; ITALY; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; MUTATION; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67849090898     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1061     Document Type: Article

References (37)

1. Jellinger KA (2008) The pathology of "Vascular dementia": a critical update. J Alzheimers Dis 14, 107-123.
2. de la Torre JC (2002) Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33, 1152-1162.
3. Du AT, Schuff N, Laakso MP, Zhu XP, Jagust WJ, Yaffe K, Kramer JH, Miller BL, Reed BR, Norman D, Chui HC, Weiner MW (2002) Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology 58, 1635-1641.
4. Duron E, Hanon O (2008) Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag 4, 363-381.
5. Kalaria RN, Ballard C (1999) Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 13(Suppl 3), S115-S123.
6. Obici L, Demarchi A, de Rosa G, Bellotti V, Marciano S, Don- adei S, Arbustini E, Palladini G, Diegoli M, Genovese E, Ferrari G, Coverlizza S, Merlini G (2005) A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. Ann Neurol 58, 639-644.
7. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L (1991) Segregation ofa missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
8. Hendriks L, Van Broeckhoven C (1996) A beta A4 amyloid precursor protein gene and Alzheimer's disease. Eur J Biochem 237, 6-15.
9. Maat-Schieman ML, van Duinen SG, Bornebroek M, Haan J, Roos RA (1996) Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): II-A review of histopathological aspects. Brain Pathol 6, 115-120.
10. Rossi G, Giaccone G, Maletta R, Morbin M, Capobianco R, Mangieri M, Giovagnoli AR, Bizzi A, Tomaino C, Perri M, Di Natale M, Tagliavini F, Bugiani O, Bruni AC (2004) A family with Alzheimer disease and strokes associated with A713T mutation ofthe APP gene. Neurology 63, 910-912.
11. Wahlund LO, BarkhofF, Fazekas F, Bronge L, Augustin M, Sjogren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P (2001) European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32, 1318-1322.
12. Cnesps - Istituto Superiore di Sanità, http://www.cuore.iss.it/ fattori-reg/calabria.asp, Accessed February 10, 2009.
13. Carlesimo GA, Caltagirone C, Gainotti G (1996) The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses ofcognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 36, 378-384.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis ofAlzheimer disease: report of the NINCDS-ADRDA Work group under the auspices ofdepartment ofHealth and Human services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
15. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus Guidelines International Workshop for the Clinical and pathological Diagnosis ofdementia with Lewy Body Disease (DLB): report ofthe Consortium on DLB. Neurology 47, 1113-1124.
16. Brun A, Englund B, Gustafson L, Passant U, Mann DMA, Neary D, Snowden JS (1994) Consensus statement: Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 57, 416-418.
17. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A (1993) Vascular Dementia; Diagnostic criteria for research studies. Report of the NINCSDS-AIREN International work group. Neurology 43, 250-260.
18. American Psychiatric Association. AP (1994) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM- IV), Washington, DC: American Psychiatric Association.
19. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32, 632-637.
20. Hutton M, Busfield F, Wragg M, Crook R, Perez-Tur J, Clark RF, Prihar G, Talbot C, Phillips H, Wright K, Baker M, Lendon C, Duff K, Martinez A, Houlden H, Nichols A, Karran E, Roberts G, Roques P, Rossor M, Venter JC, Adams MD, Cline RT, Phillips CA, Goate A (1996) Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease. Neuroreport 7(1996), 801-805.
21. Cruts M, van Duijn CM, Backhovens H, Van den Broeck M, Wehnert A, Serneels S, Sherrington R, Hutton M, Hardy J, St George-Hyslop PH, Hofman A, Van Broeckhoven C (1998) Estimation of the genetic contribution of presenilin 1 and 2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 7, 43-51.
22. Hixson g, Vernier D (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545-548.
23. Bernardi l, Maletta RG, Tomaino C, Smirne N, Di Natale M, Perri M, Longo T, Colao R, Curcio SA, Puccio G, Mirabelli M, Kawarai T, Rogaeva E, St George Hyslop PH, Passarino G, De Benedictis G, Bruni AC (2006) The effects of APOE and tau gene variability on risk of frontotemporal dementia. Neurobiol Aging27, 702-709.
24. Combarros O, Sánchez-Guerra M, Llorca J, Alvarez-Arcaya A, Berciano J, Peña N, Fernández-Viadero C (2000) Polymorphism at codon 129 of the prion protein gene is not associated with sporadic AD. Neurology 55, 593-595.
25. Armstrong J, Boada M, Rey MJ, Vidal N, Ferrer I (2004) Familial Alzheimer disease associated with A713T mutation in APP. Neurosci Lett 370, 241-243.
26. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC (2002) Subcortical ischaemic vascular dementia. Lancet Neurol 1, 426-436.
27. de Leeuw FE, Richard F, de Groot JC, van Duijn CM, Hofman A, Van Gijn J, Breteler MM (2004) Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke 35, 1057-1060.
28. de Leeuw FE, de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J, M.M. Breteler MM (1999) A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol 46, 827-833.
29. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, Hofman A, Jolles J, van Gijn J, Breteler MM (2001) Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 70, 9-14.
30. Laws SM, Perneczky R, Drzezga A, Diehl-Schmid J, Ibach B, Bauml J, Eisele T, Forstl H, Kurz A, Riemenschneider M (2007) Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia. Am J Psychiatry 164, 1577-1584.
31. Pastor P, Roe CM, Villegas A, Bedoya G, Chakraverty S, García G, Tirado V, Norton J, Ríos S, Martínez M, Kosik KS, Lopera F, Goate AM (2003) Apolipoprotein E epsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred. AnnNeurol 54, 163-169.
32. Mead S, Webb TE, Campbell TA, Beck J, Linehan JM, Rutherfoord S, Joiner S,Wadsworth JD, Heckmann J, Wroe S, Doey L, King A, Collinge J (2007) Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129. Neurology 69, 730-738.
33. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K et al (1995) Cloning ofa gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
34. Heyer E, Toupance B, Perri C, De Vito O, Foncin JF, Bruni AC (2003) Manic depressive illness in a founder population. Eur J Hum Genet 11, 597-602.
35. De Jonghe C, Zehr C, Yager D, Prada CM, Younkin S, Hendriks L, Van Broeckhoven C, Eckman CB (1998) Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion. Neurobiol Dis 4, 281-286
36. Roks G, Van Harskamp F, De Koning I, Cruts M, De Jonghe C, Kumar-Singh S, Tibben A, Tanghe H, Niermeijer MF, Hofman A, Van Swieten JC, Van Broeckhoven C, Van Duijn CM (2000) Presentation ofamyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692). Brain 123,2130-2140.
37. Alzheimer Disease & Frontotemporal Dementia Mutation Database, http://www.molgen.ua.ac.be/ADMutations, Accessed February 6, 2009.